金陵药业 (000919)

JINLING PHARMACEUTICAL CO.,LTD

ASZ

Tags

Elderly Care ConceptVenture Capital ConceptInnovative DrugsMedical Aesthetics ConceptPharmaceutical ManufacturingSmall Cap State-Owned EnterprisesYesterday's OutperformersSmart HealthcarePrivate Hospitals

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 62192.45
  • Circulating A-Shares(W): 62176.67
  • Earnings Per Share(RMB): 0.1101
  • Net Assets Per Share(RMB): 6.0803
  • Operating Revenue(W RMB): 238014.30
  • Total Profit(W RMB): 8971.11
  • Net Profit Attributable to Parent(W RMB): 6845.83
  • Net Profit Growth Rate(%): -4.08
  • Weighted Return on Equity(%): 1.8000
  • Operating Cash Flow Per Share(RMB): 0.1430
  • Undistributed Profit Per Share(RMB): 2.6726
  • Capital Reserve Per Share(RMB): 1.7448

2. Main Business

The main business covers:

  • Pharmaceutical Manufacturing
  • Medical Device Manufacturing
  • Medical, Health and Elderly Care Services

3. Company Basic Information

  • Company Name: Jinling Pharmaceutical Company Limited
  • Listing Date: 1999-11-18
  • Industry: Pharmaceutical Manufacturing
  • Address: Jinling Pharmaceutical Building, No. 238 Zhongyang Road, Nanjing City, Jiangsu Province
  • Website: www.jlyy1999.com
  • Company Profile: The company was established on September 8, 1998, as a joint-stock company initiated by Nanjing Jinling Pharmaceutical (Group) Co., Ltd., the Management Bureau of Fuzhou General Hospital of Nanjing Military Region, the Management Bureau of Suzhou Enterprises of Nanjing Military Region Logistics Department, the First Branch of the Management Bureau of Nanjing Enterprises of Nanjing Military Region Logistics Department, and the Management Bureau of Xuzhou Enterprises of Nanjing Military Region Logistics Department. The initiator, Nanjing Jinling Pharmaceutical (Group) Co., Ltd., contributed its affiliated Jinling Pharmaceutical Factory, and other initiators respectively contributed the evaluated and confirmed operating net assets of Fuzhou Meifeng Pharmaceutical Factory, Zhejiang Tianfeng Pharmaceutical Factory, Nanjing Jinwei Natural Beverage Company, and Hefei Limin Pharmaceutical Factory, totaling 260.0255 million yuan, which were converted into 200 million shares at a ratio of 76.92%. After issuing 80 million public shares (including 8 million shares allocated to investment funds) on August 27, 1999, the company's total share capital reached 280 million shares. Its 80 million public shares were listed and traded on the Shenzhen Stock Exchange on November 18, 1999.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Nanjing Xingong Investment Group Co., Ltd. General Legal Person 22794.38 38.61
2 Fuzhou Investment Management Co., Ltd. General Legal Person 2300.37 3.90
3 Hefei Industrial Investment Holding Co., Ltd. General Legal Person 971.13 1.65
4 Zhejiang International Trade Group Co., Ltd. General Legal Person 622.49 1.05

5. Concept Sectors

  • Venture Capital Concept
  • Elderly Care Concept
  • Private Hospital
  • Smart Healthcare
  • Medical Aesthetics Concept
  • Innovative Drugs
  • Recent Highs
  • Strong Yesterday
  • Small-Cap State-Owned Enterprise

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information